Related by context. Frequent words. (Click for all words.) 63 Irinotecan 61 Microspheres 61 Pivotal Phase III 60 cutaneous T cell 60 undergoing coronary angioplasty 59 Bone Graft 59 secondary hyperparathyroidism 59 Pivotal Trial 58 hematologic diseases 58 Colorado Coagulation Endocrine Sciences 58 Completes Enrollment 58 Amrubicin 57 TORISEL 57 R sorafenib tablets 57 photodynamic therapy PDT 57 relapsed multiple myeloma 57 Metastatic Melanoma 57 Doxorubicin 57 ovarian breast 57 AA amyloidosis 57 pancreatic insufficiency 57 Monoclonal Antibody 56 orphan medicinal product 56 Phase III Clinical Trial 56 pseudobulbar affect PBA 56 FDA Clears 56 Patients Treated 56 FDA Clearance 56 relapsed refractory multiple myeloma 56 ophthalmic diseases 56 Chronic Idiopathic Constipation 56 ALN TTR# 56 pancreatic NET 56 Drug Candidate 56 Metastatic Colorectal Cancer 55 Receives FDA Clearance 55 calcineurin inhibitors 55 diabetic macular edema DME 55 carcinoid tumors 55 Advanced Prostate Cancer 55 inflammatory autoimmune 55 myelodysplastic syndrome MDS 55 commercializing therapeutic 55 relapsing forms 55 GEM #S 55 hepatitis C HCV 55 Chronic Hepatitis C 55 non alcoholic steatohepatitis 55 Radiopharmaceuticals 54 opioid induced constipation 54 k Clearance 54 MPS VI 54 gastrointestinal stromal tumors 54 aHUS 54 refractory Hodgkin lymphoma 54 advanced carcinoid 54 Carboplatin 54 Chronic Lymphocytic Leukemia 54 urologic disease 54 Elderly Patients 54 osteoarthritis rheumatoid arthritis 54 J Am Acad 54 vertebral compression fractures 54 Overactive Bladder 54 Lenalidomide 54 PEGylation technology 54 symptomatic uterine fibroids 54 chronic plaque psoriasis 54 Clinical Trial Results 54 Acute Myeloid Leukemia AML 54 retinal vein occlusion 53 mTOR inhibitor 53 root = typeof 53 treat cardiac arrhythmias 53 Orphan Medicinal Product 53 superficial bladder cancer 53 Inc Therapeutic Competitors 53 lymphoma CTCL 53 Peripheral Artery Disease 53 Wet AMD 53 patients undergoing percutaneous 53 BioMarin develops 53 Phase III Trial 53 glioblastoma multiforme GBM 53 Bevacizumab 53 degenerative disorders 53 SHPT 53 phase IIb clinical 53 diabetic peripheral neuropathy 53 plus gemcitabine 53 leukemia CLL 53 transmucosal film 53 Presents Positive 53 autologous cell 53 non squamous 53 N methyl 53 commercializes proprietary 52 acute decompensated heart 52 relapsing multiple sclerosis 52 Patient Enrollment 52 Terumo Corporation